10 Things You Didn’t Know About Joseph Hernandez

​Joseph Hernandez is a recognized leader in early-stage tech development and biotech entrepreneurship. According to CrunchBase, Hernandez is also well-knowledgeable in areas such as molecular genetics, finance, biology, marketing, and epidemiology. Hernandez has successfully established and led six entrepreneurial organizations, including the Blue Water Vaccines, where he is currently the Chief Executive Officer. In this post, we will discuss the ten things you didn’t know about Joseph Hernandez.

1. He was in charge of Sales and Marketing at Merck

Between 1998 and 2001, Hernandez worked in Sales and Marketing at Merck, which is a leading global biopharmaceutical company that has been producing vaccines for most of the world’s most puzzling illnesses. During his two years and 2-month stay in the company, he helped in the marketing of Merck’s vaccines, prescription medicines, animal health products, and biological therapies. To date, Merck is leading in the research to invent ways of preventing and treating diseases such as cardiometabolic diseases, Alzheimer’s disease, Ebola, Cancer, and emerging animal diseases.

2. He was a senior manager at Digene

Joseph Hernandez was a senior manager at Digene between 2003 and 2005. During these two years, he helped many customers gain critical molecular insights from data interpreted by bioinformatics software. Digene, now known as QIAGEN, mainly deals with sample technologies that isolate and process RNA, DNA, and proteins from tissue, blood, and other materials.

3. He was the president and CEO of Signal Genetics

Hernandez was the president and Chief Executive Officer of Signal Genetics between July 2010 and February 2012. Signal Genetics is a well-known organization with its headquarters in New York and has a workforce of about 50-200 employees. The company mainly provides detailed, accurate, and personalized diagnostic results to help cancer patients and their healthcare providers determine a suitable treatment option.

4. He was a Senior Advisor of the Denmark Government

Between 2012 and 2013, Joseph Hernandez served as a Senior Advisor in the Ministry of Foreign Affairs of the Denmark Government. As a Senior Advisor, he was in charge of ensuring that the country’s values and interests relate to that of other countries worldwide in a manner that advocates for security, freedom, and the welfare of its citizens. During this one year, he helped the Ministry of Foreign Affairs in Denmark perform the following activities effectively; Export and Investment Promotion, Development Policy and Cooperation, Trade Policy, Foreign and Security Policy, Public Diplomacy, and handling Consular Services.

5. He was the Chairman of Ember Therapeutics

Joseph Hernandez worked as the Chairman of the Board at Ember Therapeutics between April 2014 and January 2019. Ember Therapeutics is a product-based organization that utilizes world-class biology expertise in trying to understand the mechanisms of selective insulin response to be used as secondary treatment options for metabolic diseases such as obesity and Type 2 diabetes. The company has employed around 11-50 employees and has built its Headquarters at Watertown, MA.

6. He was an executive board member of the Tech Council of Maryland

Hernandez was an Executive board member of the Tech Council of Maryland between January 2007 and March 2011. As an executive board member of Maryland Tech Council (MTC), he provided the biotech and tech communities with resources such as the MdBioLab program and the Maryland Health Care Product Development Corporation (MHCPDC) to promote the biomedical industry in the state. Additionally, the MdBioLab program involves the construction of mobile bioscience laboratories that advocate “early-stage” biomedical investment in various Maryland high schools that teach science literacy.

7. He was a product manager at Affymetrix

Joseph Hernandez worked as a product manager at Affymetrix between 2001 and 2003. During these two years, he helped the company solve complex analytical problems, increase laboratory productivity, increase customer life sciences research, deliver medicines to the market, and improve customer diagnostics. Affymetrix was acquired by Thermo Fisher Scientific Inc. and is a world-leading company in-service science with approximately 65,000 workers worldwide and revenues exceeding 20 billion USD.

8. He studied at Yale University.

Joseph Hernandez completed his Master of Science MSc in Chronic Disease Epidemiology and Biostatistics at Yale University between 2017 and 2021. Yale University is among the leading educational institutions that have inspired the minds of various successful people in the world. With its location in New Haven, Connecticut, Yale University brings ideas and people together around the globe for a positive impact. Moreover, Yale University is a research university that mainly focuses on the development of its students and encourages expansive learning as a vital way of life.

9. He studied at the University of Florida

Between 1996 and 1998, Hernandez did his Master of Science MSc in Microbiology and Molecular Genetics at the University of Florida located in Gainesville, Florida. The University of Florida is the largest, oldest, and most comprehensive educational institution in the state. It is also among the state’s most academically diverse major public universities, with a long successful history of developing programs in international research, service, and education.

10. He is the founder and Chief Executive Officer of Blue Water Vaccines, Inc

Joseph Hernandez is the founder, and currently, the CEO of Blue Water Vaccines, Inc. Blue Water Vaccines is a biotechnology company that develops influenza vaccines to protect humans from any influenza strain. Joseph Hernandez claimed to have full confidence and support for the universal influenza vaccine in protecting people from the various influenza strains. With its headquarters in Cincinnati, Oh, the company also focuses on developing other transformational vaccines to help solve various significant health problems worldwide. Currently, the company is developing a universal flu vaccine that protects any virulent strain and a Streptococcus pneumoniae vaccine designed to specifically target the highly infectious middle ear infections, referred to as Acute Otitis Media (AOM).

Bottom Line

Joseph Hernandez, the CEO, and founder of Blue Water Vaccines, has raised over $150M in capital revenue and extensively commercialized his company’s products. According to topionetworks, the company aggregate gross proceedings are expected to amount to 20 million USD, before deducting commissions, discounts, and other company expenses. Moreover, Hernandez is skilled in several areas such as Biotechnology, Entrepreneurship, Hardware Diagnostics, Marketing, Business Development, Strategic Planning, among others.